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Abstract
Integration of retroviral vectors in the human genome follows non random patterns that favor insertional deregulation of
gene expression and may cause risks of insertional mutagenesis when used in clinical gene therapy. Understanding how
viral vectors integrate into the human genome is a key issue in predicting these risks. We provide a new statistical method
to compare retroviral integration patterns. We identified the positions where vectors derived from the Human
Immunodeficiency Virus (HIV) and the Moloney Murine Leukemia Virus (MLV) show different integration behaviors in human
hematopoietic progenitor cells. Non-parametric density estimation was used to identify candidate comparative hotspots,
which were then tested and ranked. We found 100 significative comparative hotspots, distributed throughout the
chromosomes. HIV hotspots were wider and contained more genes than MLV ones. A Gene Ontology analysis of HIV targets
showed enrichment of genes involved in antigen processing and presentation, reflecting the high HIV integration frequency
observed at the MHC locus on chromosome 6. Four histone modifications/variants had a different mean density in
comparative hotspots (H2AZ, H3K4me1, H3K4me3, H3K9me1), while gene expression within the comparative hotspots did
not differ from background. These findings suggest the existence of epigenetic or nuclear three-dimensional topology
contexts guiding retroviral integration to specific chromosome areas.
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Introduction
Seminal clinical studies have recently shown that transplantation
of stem cells, genetically modified by retroviral vectors, may cure
severe genetic diseases such as immunodeficiencies [1,2], skin
adhesion defects [3] and lysosomal storage disorders [4]. Unfortu-
nately, some of these studies also showed the limitations of retroviral
gene transfer technology, which may cause severe and sometimes
fatal adverse effects. In particular, insertional activation of proto-
oncogenes by vectors derived from the Moloney murine leukemia
virus (MLV) caused T-cell lymphoproliferative disorders in five
patients undergoing gene therapy for X-linked severe combined
immunodeficiency [5,6], and pre-malignant expansion of myeloid
progenitors in two patients treated for chronic granulomatous
disease [7]. Pre-clinical experiments showed that HIV-derived
lentiviral vectors are less likely to cause insertional gene activation
than MLV vectors. Most of the studies on retroviral integration
preferences, however, have beencarried out on cell lines that poorly
represent the genomic characteristics of somatic stem cells, or on
limited numbers of patient-derived cells. A better understanding of
the interactions between retroviral vectors and the genome of
clinically relevant target cells may provide a more rational basis for
predicting genotoxic risks in clinical gene therapy.
A large number of studies have focused on the molecular
mechanisms by which mammalian retroviruses choose their
integration sites in the target cell genome. After entering a cell,
the retroviral RNA genome is reverse transcribed into double-
stranded DNA, and assembled in pre-integration complexes (PICs)
containing viral as well as cellular proteins. PICs associate with the
host cell chromatin, where the virally encoded integrase mediates
proviral insertion in the genomic DNA. Retroviral integration is a
non-random process, whereby PICs of different viruses recognize
components or features of the host cell chromatin in a specific
fashion [8]. The LEDGF/p75 protein has been identified as the
main factor tethering HIV PICs to active chromatin [9], while
mechanisms underlying integration site selection of other retrovi-
ruses remain largely unknown. We recently showed that MLV-
derived vectors integrate preferentially in hotspots near genes
involved in the control of growth, differentiation and development
of hematopoietic cells and flanked by defined subsets of
transcription factor binding sites; this suggested that MLV PICs
are tethered to transcriptionally active regulatory regions engaged
by basal components of the RNA Pol II transcriptional machinery
[10,11]. On the contrary, HIV-derived vectors target expressed
genes in their transcribed portions away from regulatory elements,
suggesting a different evolutionary strategy for these two viruses.
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poorly understood. The concept of integration ‘‘hotspot’’ was
introduced to describe areas of the genome where integrations
accumulate more than expected by chance in the absence of any
selection process [10]. Hotspots therefore differ from ‘‘common
integration sites’’ (CIS), which were defined as sites recurrently
associated with virus-induced malignant expansion [12]. The final
goal in finding hotspots is to investigate genomic properties that
lead certain areas to ‘‘attract’’ or ‘‘refuse’’ integration. We
suggested in previous work that integration preferences are
dependent on the intrinsic gene density distribution and on the
type of vector [13,14].
In this paper we develop a statistical methodology to detect
‘‘comparative’’ hotspots, i.e. areas of the genome where
integration intensities of MLV and HIV appear to differ. We
do not find regions where the viruses prefer to integrate, but
where the integration patterns are different. Our approach
followed two steps: first candidate comparative hotspots were
identified by comparing variability bands around estimated
integration intensities along the genome, and then each
candidate comparative hotspot was tested in turn. After
multiplicity correction we produced a list of 100 comparative
hotspots, ready for further biological validation. Our analysis
discriminated regions which were targeted by both viruses, most
likely on the basis of their accessibility (high content of active
genes), from regions specifically that are preferred by either
MLV or HIV. We show that HIV and MLV integrate
differently in regions spanning 0.2 to .6 Mb in the human
genome, with specific patterns. In particular, HIV-specific
hotspots are wider and contain a larger number of genes. The
preference of HIV or MLV for these regions cannot be
explained by the known viral target site selection preferences,
or by the expression characteristics of the targeted genes,
suggesting the existence of epigenetic or nuclear topology
contexts that drive retroviral integration to specific chromosome
territories.
Results
We developed a new statistical method to compare the
integration preferences of distinct retroviral vectors in the human
genome and we used it to analyze a collection of ,30,000 MLV
and HIV-vector insertion sites in human CD34
+ hematopoietic
stem-progenitor cells [15]. Figure 1 illustrates how the method-
ology performs on chromosome 6. We compared the two
integration propensities for each arm and strand separately. The
blue 99% variability band corresponds to the integration density of
HIV, estimated from our data; in red the band for MLV. When
the two bands stay apart, one above the other, a candidate
comparative hotspot is identified as the segment of such empty
intersection. These are depicted as blue and red thick segments in
the center of the plot. In chromosome 6 we identified 12 candidate
hotspots where MLV shows more integrations than HIV, and 5
candidate hotspots where HIV is dominating. In most of
chromosome 6, we found no differences in integration patterns.
Note the high peak of integration on the p-arm for HIV, on both
strands, corresponding to the MHC locus. Similar plots for all
chromosomes are available in supplementary material Figure S1
and Figure S2.
The panels of Figure 2 show two typical situations in detail. The
panel A (left side) from the HIV HLA locus in chromosome 6, arm
p; upper panel refers to strand+, lower panel refers to strand -. We
see how the estimated variability bands, around the non-
parametrically estimated integration densities, are clearly apart
from each other. The bands overlap at both ends of the
comparative hotspot, which is therefore well defined. The width
of the bands describes the statistical uncertainty attached to the
estimated densities: in both cases the MLV bands are quite thin, as
there are a total large number of integrations. The bands for HIV
are larger; the exact density function is difficult to estimate with
limited sample size. Despite the uncertainty, the candidate hotspot
in panel A is clearly identified. The panels B of Figure 2 show a
candidate comparative hotspot in the plus strand of chromosome
6, arm q, which has no corresponding in the minus strand. In
other locations of the genome, the two bands often overlap simply
due to lack of data, rather than because the two vectors are equally
distributed. This indicates that our method will leave undiscovered
comparative hotspots (false negatives). Not all the candidate
comparative hotspots that we identified were clearly distinguish-
able.
Our analysis led to 256 candidate comparative hotspots on all
chromosomes (see, supplementary material, Table S1). Each
candidate comparative hotspot was then tested individually. We
computed odds ratios, between HIV and MLV odds of
integrations in each hotspot, and tested the null hypothesis that
the odds ratio is one. P-values were then corrected for multiple
testing. This reduced the number of significative comparative
hotspot to 100, reported in Table 1.
The length of the hotspots varies between ca. 200,000 bp and
7,000,000 bp, but most are longer than 10
6 bp. They include
between 1 and 179 genes. Of the 100 significative comparative
hotspots, 49 have a higher density of HIV integrations (lengths
ranging between 378,200 and 6,857,000 bp; median:
2,651,000 bp, 2,027 unique target genes) while 51 contain a
higher MLV density (lengths ranging between 211,300 and
6,021,000 bp; median: 1,319,000 bp, 475 unique target genes).
The median length of MLV hotspots is about the half of the
median length of HIV hotspots with a significative difference (p-
value: 2.108N10
206; Mann-Whitney test, p-values computed by
permutations). The wideness of HIV hotspots only partially
accounts for the higher number of target genes compared to
Author Summary
Understanding how retroviral vectors integrate in the
human genome is a major safety issue in gene therapy,
since a concrete risk of developing tumors associated with
the integration process has been observed in several
clinical trials. Statistical analyses confirmed the non
randomness of the integration. Where and why do virus-
specific integrations tend to accumulate in the genome?
We compared integration preferences of two retroviral
vectors derived from HIV and MLV, which are used in most
gene therapy trials for hematological disorders, in their
actual clinical targets, i.e., human hematopoietic stem/
progenitor cells. We developed a new statistical method to
find areas of the genome, called comparative hotspots,
where integration preferences are significantly different.
We modeled the integration process as a stochastic
process, so that integration sites are seen as samples from
an unknown virus-specific probability density function.
Thus, the problem became to identify areas where two
empirical density functions differ significantly. The com-
parison of nonparametric variability bands around the
estimated integration densities allowed identifying and
ranking candidate comparative hotspots. Results indicated
clear differential patterns of integration between HIV and
MLV, leading to new hypotheses on the mechanisms
governing retroviral integration.
Comparative Retroviral Hotspots
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per hotspot normalized by the hotspot length (see Figure 3: p-
value=1.953*10
28, Mann-Whitney test, p-values computed by
permutations). This hints at gene density as a critical parameter for
HIV integration site selection and is in accordance with the recent
finding that MLV integration is associated to transcription
regulatory regions rather than to genes [11,15,16].
To investigate the categories of genes preferentially targeted by
the comparative hotspots we performed a Gene Ontology (GO)
classification of HIV and MLV target genes (supplementary
material, Table S2). Among the 2,027 genes in the comparative
hotspots with HIV preference, the analysis showed a significant
enrichment over the background (0.005,p-values,0.05, Fischer’s
exact test with Bonferroni correction for multiple testing) for genes
involved in antigen processing and presentation, and in hormone
nuclear receptor activity. Remarkably, both GO terms exclusively
contained genes located in the MHC locus on chromosome 6
(highest peak in Figure 1). Among the 475 MLV targets, genes
participating in adaptive immune response, signal transduction,
and regulation of biological processes were over-represented
(0.005,p-values,0.05). Differently from HIV targets, these genes
did not belong to the same chromosomal region.
The annotation of oncogenes [17] (Sanger Cancer Gene Census,
http://www.sanger.ac.uk/genetics/CGP/Census) incorporated into
comparative hotspots (see the full gene Table S1 in supplementary
material) did not reveal a significant difference in the targeting
Figure 1. Integration densities of HIV and MLV in CD34
+ cells, for chromosome 6. We analyzed each strand separately: the upper half is
the + strand and the lower the - strand. In blue the estimated variability band at level 0.99 for HIV integrations (n=1629), in red for MLV (n=1815).
Candidate comparative hotspots are plotted in the two central x-axes, the color indicating which of the two vectors had stronger integration
intensity (HIV: blue; MLV: red). In the other four x-axes, each tick represents one integration site, with the same color code. Because of resolution,
many ticks fall on the same point and cannot be distinguished.
doi:10.1371/journal.pcbi.1002292.g001
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(0.045 for HIV vs. 0.050 for MLV, p-value: 0.4109) or the sole genes
in the 100 significative comparative hotspots (0.047 for HIV vs. 0.054
for MLV, p-value: 0.06707). We next investigated the relation
between gene expressions and comparative integration hotspots. We
compared thefrequencyofexpressedgenesbelongingtocomparative
integration hotspots with the frequency of transcribed genes located
elsewhere in the genome. After multiple testing corrections, we found
just one hotspot with increased presence of expressed genes with
respect to the genomic baseline (hiv_55, adjusted p-value 0.02800; see
Table S1, supplementary material for full results). Three comparative
hotspots, all with higher MLV density (mlv_50, mlv_51, mlv_124,
p-values: 0.00075, 00.00197, 0.00778 respectively), showed instead a
reduced presence of expressed genes.
Since there is strong evidence of association between integration
sites and specific histone modifications [18,19,20], we also
investigated the histone methylation [21] density in comparative
hotspots, defined as the methylation intensities (i.e., the number of
ChIP-seq reads) in each comparative hotspot, divided by the
hotspot length; the same was done for the histone variant H2A.Z.
Figure 2. Two typical situations in comparative hotspots. In panel A (left side) the bands don’t overlap in plus and minus strands, suggesting
the presence of two candidate comparative hotspots (hotspots ID: hiv_36 and hiv_40, see supplementary material, Table S1). Differences in
integration densities in one versus the other strand may reflect a preferential integration orientation at that particular locus. In panel B (right side) the
bands don’t overlap in the plus strand (upper panel) whereas on the minus strand they do (lower panel), suggesting only one candidate (hotspot ID:
mlv_43, see supplementary material, Table S1). These examples are taken from chromosome 6.
doi:10.1371/journal.pcbi.1002292.g002
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associated to transcription or heterochromatin in HIV vs. MLV
hotspots using the Welch statistic test, which does not assume the
same variance for the two groups, with p-values computed by
permutations. After adjustment for multiplicity (Bonferroni-Holm)
three methylations and the one histone variant analyzed were
found to have different mean density in HIV vs. MLV hotspots
(H3K4me1, H3K4me3, H3K9me1, H2AZ; adjusted p-values:
0.000096, 0.000010, 0.020986, 0.000018 respectively). Results are
summarized in table 2.
The construction of the variability bands of an integration
density depends on a design smoothing parameter, as described in
Table 1. Comparative Hotspots.
virus chr strand start end length OR adjusted-p # genes
hiv chr11 + 63052973 68240744 5187771 6.73 1.16e-052 177
hiv chr6 2 29857643 34003291 4145648 25.59 7.53e-046 171
hiv chr16 2 0 3573133 3573133 9.82 1.85e-045 171
hiv chr11 2 63408683 68252636 4843953 5.23 6.59e-045 169
hiv chr6 + 29653216 33939640 4286424 31.23 2.42e-043 179
hiv chr16 + 0 3106569 3106569 13.06 3.32e-042 153
hiv chr1 + 0 4770330 4770330 14.32 1.66e-027 89
hiv chr3 2 46696908 53554160 6857252 4.03 1.58e-025 159
hiv chr17 2 70567573 74031223 3463650 4.35 1.14e-024 81
hiv chr17 + 77083925 78700791 1616866 8.53 2.45e-024 56
hiv chr9 + 136302969 140273252 3970283 7.96 4.03e-023 97
hiv chr1 2 151528646 154707353 3178707 4.77 4.52e-020 114
hiv chr9 2 135483396 140273252 4789856 6.70 1.62e-019 105
hiv chr3 + 46805137 51013082 4207945 3.78 1.18e-014 101
hiv chr1 + 152393200 155051471 2658271 3.61 1.36e-014 97
hiv chr8 + 143266499 146274826 3008327 5.29 1.76e-013 94
hiv chr17 2 76476613 78537508 2060895 4.42 1.85e-013 67
hiv chr2 2 26376098 28509807 2133709 5.32 4.64e-013 51
hiv chr8 2 142937251 146274826 3337575 5.58 7.07e-013 94
hiv chr17 + 71000437 72361727 1361290 5.03 2.53e-012 50
mlv chr18 + 71458533 76117153 4658620 14.38 1.65e-011 17
mlv chr21 2 38477753 39470763 993010 23.96 1.13e-010 5
hiv chr22 + 48573053 49691432 1118379 6.34 8.99e-010 38
hiv chr20 2 60274607 62435964 2161357 6.34 8.99e-010 60
mlv chr17 + 51301476 53344785 2043309 15.10 5.64e-009 12
hiv chr4 2 0 3791201 3791201 4.67 1.23e-008 61
hiv chr16 + 86724460 88827254 2102794 4.08 3.24e-008 45
mlv chr20 + 51190248 52356969 1166721 13.94 5.88e-008 6
hiv chr19 + 54403063 55308772 905709 5.97 7.82e-008 47
mlv chr12 + 115324321 117477353 2153032 10.89 1.10e-007 16
mlv chr6 2 5956453 7313927 1357474 33.96 1.20e-007 6
hiv chr2 + 26617223 28096371 1479148 3.50 1.34e-007 47
hiv chr19 2 54293977 55393350 1099373 5.65 4.17e-007 54
hiv chr22 2 48767773 49691432 923659 4.40 4.85e-007 33
hiv chr2 2 185808293 188459285 2650992 8.25 5.51e-007 7
mlv chr18 2 71648647 73379689 1731042 10.02 1.04e-006 5
hiv chr12 + 47052128 48977359 1925231 4.53 1.39e-006 53
hiv chr15 + 38942654 41945536 3002882 3.80 2.97e-006 61
mlv chr20 2 51173685 52422011 1248326 9.58 3.17e-006 6
mlv chr3 + 70940451 72487606 1547155 9.36 5.55e-006 4
List of the 40 top hotspots for which the p-value (Bonferroni-Holm adjusted [41]) of the odds ratio (OR) being equal to one, was below 0.05. The first column indicates
which virus had most integrations. Columns 2–5 locates the hotspot on its chromosome. Column 6 contains the width of the hotspot (min: 211313 bp, max: 6857252).
The OR (column 7) was always defined to be larger than 1 (min: 2.24, max: Inf). The adjusted p-values are in column 8. The number (#) of genes included in each
hotspot is in the last column (range: 1 to 179). Full table is available in supplementary material Table S1.
doi:10.1371/journal.pcbi.1002292.t001
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parameters controls the regularity of the variability bands and
therefore had an effect on the comparison. We estimated the
smoothing parameters in an optimal fashion (in correspondence to
which results were reported), but also studied robustness of the
hotspots by varying them systematically. We systematically
checked if a comparative hotspot would have persisted for larger
and smaller smoothing parameters. Figure 4 shows the results of
such a sensitivity study for two strands of chromosome 6. The
middle line, corresponding to 1, shows the hotspot identified by
the two optimal smoothing parameters, while above and below
that we see how hotspots would grow and shrink by increasing and
reducing the smoothing level. It is important that the chosen
segments at level 1 continue to appear for values just above and
under, as happened systematically. This visual inspection strength-
ens the validity of the way we chose the smoothing parameters. See
Methods for more details and supplementary material Figures S3,
S4, S5, S6, S7 and S8 for robustness plots for all chromosomes.
Discussion
Integration of MLV-derived retroviral vectors may have
significant consequences on gene expression and homeostasis of
transduced and transplanted target cells, particularly in the
hematopoietic system. The enhancer activity of the MLV LTRs
may de-regulate proto-oncogenes, and cause pre-neoplastic clonal
expansion [7,22], leukemic transformation without clonal expan-
sion [5,6,23], or no apparent adverse effect [1] depending on the
disease context and a number of still ill-defined factors. Integration
sites can be used as markers of clonality to study the clonal
dynamics of transduced cells in vivo, and provide important clues to
predict the potential genotoxicity of MLV integration in a specific
Figure 3. Gene density of HIV and MLV comparative hotspots. Histogram of the number of target genes per hotspot normalized by hotspot
length in HIV (blue bars, upper panel) and MLV (red bars, lower panel).
doi:10.1371/journal.pcbi.1002292.g003
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pyrosequencing to derive high-definition maps of MLV and HIV
integration sites in the genome of human CD34
+ hematopoietic
progenitors. As previously reported [14], MLV integrations were
clustered around gene regulatory elements (promoters, enhancers,
evolutionarily conserved non-coding regions) bearing epigenetic
marks of active transcription (H3K4me1, H3K4me2, H3K4me3,
H3K9Ac) and specialized chromatin configurations (H2A.Z). On
the contrary, HIV integrations occurred away from regulatory
elements, and are associated with histone modification enriched in
the body of transcribed genes (H3K36me3 and H2BK5me1). In
both cases, statistical analysis identified hotspots of clustered
integrations with strong correlation with transcriptional activity,
using random integration datasets as controls.
In this study, we identify broad areas of the genome where HIV
and MLV integrate differently; therefore it was not expected to
find comparative hotspots in areas of high gene expression. This is
in accordance with the fact that a single hotspot showed an
increased expression level with respect to the rest of the genome.
We used non-parametric density estimation and variability bands
to identify regions of the genome as candidate comparative, i.e.,
virus-specific, hotspots. Thereafter, these were tested for signifi-
cance. The first step delivers a series of bins, of variable length,
were the two integration frequencies appear to be different. This
strategy is more effective than binning the chromosome with equal
size bins, since some of them might not be large enough to contain
enough integrations. An optimal bin size algorithm, producing a
constant bun size, would easily divide a chromosome in a dozen
bins, which would be too large to be of practical interest as
candidate hotspots. Our approach generates a list of bins of
variable and adaptive length, only in areas of interest. Interest-
ingly, this analysis identified large genomic regions (0.2 to .6M b
in length) rather than local (,100 kb) hotspots. Most genomic
regions are targeted by both virus types, most likely because they
contain a high proportion of active genes and regulatory elements.
Some regions, however, are targeted by either virus in a specific
fashion, where HIV-specific hotspots tend to be larger in size and
to contain more genes. The expression and gene ontology
characteristics of the genes contained in MLV and HIV-specific
regions, however, were comparable, and there are no obvious
characteristics that would predict such a striking virus-specific
preference. While MLV-specific regions are enriched for histone
modifications/variants correlated with active regulatory regions
(H3K4me1, H2A.Z), HIV-specific regions have a higher density of
H3K4me3, associated to active transcription start sites. Although
counterintuitive, given the well-known MLV preference for
transcription start sites, this might be simply explained by the
higher gene content of HIV-specific hotspots. Unfortunately,
genomic distribution of HIV tethering factors, such as LEDGF/
p75, is not known, particularly for hematopoietic progenitors, and
it is therefore impossible to test whether high protein concentra-
tion in specific chromosomal region may explain the HIV-specific
preferences.
Interestingly, we found a significant comparative hotspot
spanning the entire MHC locus on chromosome 6 (from the
MHC class I to the extended MHC class II subregions [28]) with
increased HIV, but not MLV, integration propensity. Importantly,
a gene-centric hotspot definition would have failed to detect this
locus, since in this particular case intergenic regions rather than
single genes are highly targeted by HIV.
Large, virus-specific hotspots may suggest that tethering of PICs
to chromatin favors relatively wide chromosomal territories
independently from their content or local concentration of
‘‘attractive’’ features, such as GC content of DNA, binding of
factors or transcriptional complexes, nucleosome density or
epigenetic marks. This type of preference may instead reflect
larger scale, nuclear topology factors that make these regions more
accessible to one or another virus type. The modalities by which
HIV and MLV access target cell chromatin, may be a critical
factor underlying these preferences. MLV is incapable of entering
intact nuclei and requires cell division in order to integrate, while
HIV is actively imported in interphase nuclei through the nuclear
pores. MLV and HIV PICs therefore ‘‘see’’ chromatin in different
phases of the cell cycle, and may have access to different regions
simply because they are differently exposed. Recent studies
showed that alterations in the nuclear pore architecture impairs
HIV nuclear import and impacts on integration efficiency,
suggesting that access to chromatin is mediated by the nuclear
pore and may be a critical component of target site selection
[29,30]. The HIV-specific hot regions identified in this study may
Table 2. Density of histone modifications in comparative hotspots.
methylation HIV MLV p adjusted-p
mean SD mean SD
H3K27me3 0.002805 0.001179 0.003140 0.001585 0.069324 0.347210
H2AZ 0.003625 0.001441 0.004494 0.001444 2e-06 0.000018
H3K27me1 0.003399 0.000889 0.003774 0.001235 0.008568 0.050412
H3K36me3 0.006188 0.005843 0.005998 0.003063 0.766001 1
H3K4me1 0.002469 0.001630 0.003486 0.001823 6e-06 0.000096
H3K4me3 0.001617 0.001179 0.001078 0.000494 1e-06 0.000010
H3K9me1 0.006676 0.004553 0.008585 0.005302 0.00297 0.020986
H3K9me3 0.003696 0.003790 0.003555 0.001467 0.728885 1
H4K20me1 0.008214 0.005921 0.007407 0.004374 0.212219 0.846512
PolII 0.001876 0.000829 0.002016 0.001054 0.263484 0.846512
Columns 2 and 3 report the mean density of modifications and relative standard deviation in comparative hotspots with HIV abundance. Columns 4–5 are mean density
and standard deviation in MLV preferred hotspots. The p-values for the equality of the means are in column 5 (Mann-Whithney test statistics, p-values computed by
permutations) and adjusted p-values in column 6 (Bonferroni-Holm method). In bold, methylations/histone variants with significative difference.
doi:10.1371/journal.pcbi.1002292.t002
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nuclear pore. Studies are in progress to test this hypothesis in
clinically relevant target cells.
Materials and Methods
Integration within CD34
+ cells
We worked with a previously published collection of 28,382
HIV and 32,631 MLV retroviral integration sites isolated by
linker-mediated PCR (LM-PCR) and pyrosequenced by GS-FLX
Genome Sequencer (Roche/454 Life Sciences, Branford, CT)
from cord blood-derived human CD34
+ hematopoietic stem-
progenitor cells [15]. The bioinformatics pipeline used to process
crude MLV and HIV sequence reads was previously described
[15]. Briefly, valid reads 20-bp or longer were used to generate a
non-redundant dataset using the nrdb tool (available at http://
www.advbiocomp.com/blast.html in the AB-BLAST software
package). Non-perfectly redundant reads were than mapped onto
the human genome, requiring the alignment to start within the
first three nucleotides and to possess a minimum of 90% identity.
Sequences were discarded when mapping to multiple sites if they
had more than one match on the human genome differing in
identity less than 2%. Overall valid sequence recovery was similar
between MLV and HIV (13.3% and 17.3%, respectively). The
expression profile of CD34
+ cells was determined by microarray
analysis of cytokine-activated cells from three independent
umbilical cords. RNA was extracted from 1–2610
6 cells,
transcribed into biotinylated cRNA and hybridized to Affymetrix
HG-U133A plus 2.0 Gene Chip arrays.
Functional clustering analysis
Functional clustering of target genes was performed by the
DAVID 2.0 Functional Annotation Tool and EASE score, as
previously described [10]. GO categories were considered over-
represented when yielding an EASE score ,0.05, after Bonfer-
roni-Holm correction for multiple testing.
Blind regions
Certain areas of the genome cannot be scanned in order to
investigate the presence of integrations. This is mainly due to two
reasons: genome mappability and the presence of what we call
‘‘blind regions’’. Although extremely critical in determining the
randomness of single integration patterns, genome mappability
was not a concern in our comparative study, since only
unequivocally mapping reads were considered, for the comparison
of MLV and HIV integration patterns (i.e., the mappability bias, if
any, was the same for the two vectors). Blind regions instead derive
from the use of restriction enzymes and size-selection during the
integration library preparation, and represent portions of the
genome that are scarcely accessible to detection due to their
distance to the closest 39 restriction site (Figure 5). Specifically, if
this distance is shorter than the sensibility of alignment programs,
in terms of minimum length of the processable sequence,
integration is not identifiable. For example, if a viral vector
integrated 10 bps far from the closest 39 cut sequence, then from
the sequencing platform we obtained a 10 bps sequence, that for
most of alignment program is not processable. We used Blat [31]
which has minimum sequence length of 20 nt. On the other hand,
the size-fractionation step only includes fragments ,500 nt, this
being the maximum estimated length for efficient 454 bead
loading (see supplemental methods in [10]). Therefore, integra-
tions with a distance to the closest 39 restriction enzyme site of, for
example, 600 bps, would not be detected. These blind regions
need to be excluded from further analysis, as it was impossible to
determine accurately integration frequencies occurring therein.
We first identified these blind regions by looking for the position of
Figure 4. Robustness plots. Panel A: chromosome 6, arm p; strand -. Panel B: chromosome 6, arm q; strand -. Here we can observe how hotspots
would change in length and location if we were to use different smoothing parameters. Most importantly, we see that the hotspots identified at level
1, corresponding to our choice of the smoothing parameters, persist at slightly larger and smaller values, confirming their validity. At smaller levels of
smoothing many spurious hotspots appear, of very short length. There is no support from the data for these, as they either disappear for more
smoothing or they merge into larger and more robust segments. Large smoothing either impairs the creation of hotspots (as bands tend to become
large and flat) or they deliver very large hotspots, which are difficult to interpret biologically.
doi:10.1371/journal.pcbi.1002292.g004
Comparative Retroviral Hotspots
PLoS Computational Biology | www.ploscompbiol.org 8 December 2011 | Volume 7 | Issue 12 | e1002292restriction sequences over the whole genome. We then cut off the
blind regions. When performing density estimation, we skipped
blind regions and connected together successive non-blind parts.
We assumed smoothness of the density at mending points, as the
blind regions were comparably short. Once hotspots were found,
the blind areas were placed back in the original topology.
Integration analysis was performed separately for each chromo-
somal arm, so that it was not affected by the centromere, which is
a giant blind region. Furthermore, we studied separately each
strands, since blind regions are strand specific. The presence of
blind regions due to the restriction enzyme digestion is known. It
has been shown that the ‘‘invisible’’ portion of the genome is
substantially affected by the use of different and/or multiple
restriction enzymes [32]. We also found the percentage of blind
regions to be very significant, ranging from 10% up to 40% of the
length of the chromosome. For example, 30.5% of chromosome 1
was blind (total length 247.249.719 bp); see supplementary
material Table S1 for percentages for all chromosomes. Blind
regions were identified by means of a custom R-script (R ver 2.10
[33] and Bioconductor [34]) which searched for the TTAA
sequences (MseI) on the Hg18 UCSC genome. Once occurrences
were identified, blind regions were estimated as follows: from
TTAA to 20 bp downstream (due to algorithm limitation) and
from 500 bp downstream to the consecutive restriction site (due to
deep sequencing platform limitation).
Statistics
The integration dynamics was modelled as a stochastic process,
where integration points were considered as samples from an
unknown density function on the region of study D. We assumed
that each integration was independent of any other. Each virus
was considered as a random variable v with its own unknown
probability density function fv. Comparing integration preferences
of two viruses v1 and v2 was then turned into the statistical problem
of comparing two unknown densities fv1 and fv2, defined on the
same genomic range D, based on an independent and identically
distributed sample from each of the two densities. The samples
were allowed to have different sample size. Our approach was fully
nonparametric and led to candidate comparative hotspots, which
were then individually tested. Specifically, non-parametric kernel
density estimation with Gaussian kernels was used [35]. In a
basepair x, the estimated density ^ f fh x ðÞ , based on the sample
x1,x2 ...,xn ðÞ in D, is given by the kernel density estimator
^ f fh x ðÞ ~
1
n
X n
i~1
Kh x{xi ðÞ ~
1
nh
X n
i~1
K
x{xi
h
  
where K(?) is the kernel and h.0 is the smoothing parameter
(bandwidth). We used the Gaussian kernel
Ku ðÞ ~
1
ﬃﬃﬃﬃﬃﬃ
2p
p e
{1
2u2
:
Notice the scaling of the kernel with h, which controls how much
weight each integration xi has in the estimate at a basepair x.W e
performed a small approximation, as the kernel should integrate to
1 over D, and the domain D is discrete. However, the resolution at
basepair level of the chromosome arms is extremely high, so that
the effect of this was negligible.
We wished to construct simultaneous confidence bands (at 0.99
level, say) for the two densities to be compared, in order to identify
areas (if any) where the confidence bands did not overlap: in such
segments of D, one density must clearly be below the other.
However, such confidence bands depend on the second derivative
of the unknown density, controlling both bias and variance;
approximations are available only in some special cases under very
strong conditions. We instead calculated pointwise variability
bands around the estimated densities, where the variation in the
density estimates were taken into account, but the bias was
ignored. The segments of the chromosome D where the two
Figure 5. Blind regions. These plots illustrate the presence of blind regions, which are scattered over the genome and usually short, but
occasionally also of appreciable length (panel A: mlv_53, chromosome 7, arm p strand -; panel B: mlv_147, chromosome 22 arm q, strand +). Not all
the candidate comparative hotspots that we identified were clearly distinguishable, see for example panel A.
doi:10.1371/journal.pcbi.1002292.g005
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candidate comparative hotspots. The 0.99 variability band for the
estimated density was computed [36] starting with the Taylor
expansion
Var
ﬃﬃﬃ
^ f f
q   
*
1
4
1
nh
RK ðÞ
where
RK ðÞ ~
ð
K2 x ðÞ dx
is the integral of the squared kernel function and n is the sample
size. The root transform allowed obtaining an approximation of
the variance which was independent from the unknown density.
Therefore, on the square root scale, a 1{a level error band could
be computed, using the half width
Za=2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
RK ðÞ
4nh
r
around the squared root of the estimate, whereZa=2
is the quantile
of the normal standard distribution. Then, as in [36], the edges of
this band were transformed back to the original scale as
ﬃﬃﬃ
^ f f
q
+Za=2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
RK ðÞ
4nh
r  ! 2
,
where the lower bound is set to zero if it took a negative value. We
used a~0:01.
This is not a confidence band and there is no nominal coverage
probability. The effect of the bias is to diminish modes and fill
valleys, as it depends on the curvature of f (and on the bandwidth),
see [36]. Variability bands of this type were computed for both
densities. Typically, a detected candidate comparative hotspot
(where the two variability bands had empty intersection) resulted
from a pronounced peak in one density and a valley or flat area in
the other. In these situations, adjusting for the bias would have
strengthened further the indication of a hotspot. On the other
hand, the absence of bias adjustment could in some special
situations hide a difference. This indicates that in most cases we
have identified candidate comparative hotspots conservatively.
We compared the two pointwise variability bands at level
a~0:01, one for each virus, to detect where the bands did not
overlap. These segments in D were considered as candidate
comparative hotspots. This approach is different from [37], where
bins are decided in advance, instead than being data-driven.
Though the band was computed pointwise, it inherited
smoothness from the smooth density estimate around which it
was built. For computational efficiency, the density was estimated
on a grid of points, which were then interpolated with a spline
function [38]. We did not implement any particular boundary
control at the border of the chromosome arm not flanking the
centromere.
The choice of the smoothing parameters h1 and h2, one for each
viral integration density, is important: too much smoothing would
flatten the kernel estimates, hiding every difference; too little
smoothing would lead to a too rich and fragmented identification
of comparative hotspots, with very high false positive findings. Our
choice was to perform an automatic and optimal choice of the
smoothing parameter for each density and then study how results
would change when this value was perturbed in both directions,
towards more and towards less smoothing. We chose the optimal
smoothing parameters, hopt, one for each density, using unbiased
cross-validation [39]. Briefly, hopt is chosen to minimize the
measure of closeness of ^ f f to f given by the Integrated Squared
Error
ISE ^ f f h
  
~
ð
^ f f h x ðÞ {ff ðÞ
   2
dx~
ð
^ f fx ðÞ
   2
dx{2
ð
^ f f h x ðÞ fx ðÞ dxz
ð
f 2 x ðÞ dx,
through a least square, leave-one-out crossvalidation criterion. For
this purpose we minimized the estimate of the first two terms of the
ISE (the last term does not depend on h) given by
1
n
X n
i~1
ð
^ f f {i x ðÞ
   2
dx{
2
n
X n
i~1
^ f f {i xi ðÞ ,
where ^ f f{i x ðÞdenotes the kernel estimator constructed from the
data without the observation xi. See [39,40] for more details. In
order to test sensitivity of results with respect to the choice of h,w e
reparameterized the smoothing parameter as h=hopt s, where the
sensitivity factor s was left to vary in [0.05, 20]. We then repeated
the comparison of the variability bands for the two viral
integration densities, using the crossvalidated optimal smoothing
parameter for each virus, adjusted with the same s. We plotted the
comparative hotspots while varying s, to see the robustness of each
hotspot, as in Figure 4.
Candidate comparative hotspots were then tested individually,
to confirm (or not) that the integration propensities of the two
viruses were significantly different. As many comparisons were
performed, multiple testing correction was done. We computed
the odds ratio of the two integration intensities, one for each virus,
for each candidate hotspot as
HIVinH=HIVoutH
MLVinH=MLVoutH
when HIV had a higher density and the inverse of it when the
MLV density was higher instead. Here HIVinH is the number of
integration of HIV falling inside the candidate hotspot H, HIVoutH
is the number of integration outside hotspot H, and similarly for
MLV. We computed 0.95 confidence intervals for this odds ratio
and tested the null hypothesis that the odd ratio is 1. We used the
Fisher exact test. Raw p-values were then corrected for multiple
testing by Bonferroni-Holm [41]. All computations and analyses
were performed in R and Bioconductor environment [33,34].
Supporting Information
Figure S1 Integration densities of HIV and MLV in
CD34
+ cells, for chromosomes chr1, chr2, chr3, chr4,
chr5, chr6, chr7, chr8, chr9, chr10, chr11 and chr12. We
analyzed each strand separately: the upper half is the+strand and
the lower the2strand. In blue the estimated variability band at level
0.99 for HIV integrations, in red for MLV. Candidate comparative
hotspots are plotted in the two central x-axes, the color indicating
which of the two vectors had stronger integration intensity (HIV:
blue; MLV: red). In the other four x-axes, each tick represents one
integration site, with the same color code. Because of resolution,
many ticks fall on the same point and cannot be distinguished.
(TIFF)
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CD34
+ cells, for chromosomes chr13, chr14, chr15,
chr16, chr17, chr18, chr19, chr20, chr21, chr22, chrX
and chrY. We analyzed each strand separately: the upper half is
the+strand and the lower the2strand. In blue the estimated
variability band at level 0.99 for HIV integrations, in red for
MLV. Candidate comparative hotspots are plotted in the two
central x-axes, the color indicating which of the two vectors had
stronger integration intensity (HIV: blue; MLV: red). In the other
four x-axes, each tick represents one integration site, with the same
color code. Because of resolution, many ticks fall on the same point
and cannot be distinguished. Since no integration was found in p-
arm of chromosomes chr13, chr14, chr15, chr21 and chr22, in
such cases only the q-arm was plotted.
(TIFF)
Figure S3 Robustness plots for all hotspots, chromo-
somes chr1, chr2, chr3 and chr4. The name of each figure
identifies the chromosome and the arm and strand. In these figures
we can observe how hotspots would change in length and location
if we were to use different smoothing parameters. Most
importantly, we see that the hotspots identified at level 1,
corresponding to our choice of the smoothing parameters, persist
at slightly larger and smaller values, confirming their validity. At
smaller levels of smoothing many spurious hotspots appear, of very
short length. There is no support from the data for these, as they
either disappear for more smoothing or they merge into larger and
more robust segments.
(TIFF)
Figure S4 Robustness plots for all hotspots, chromo-
somes chr5, chr6, chr7 and chr8. The name of each figure
identifies the chromosome and the arm and strand. In these figures
we can observe how hotspots would change in length and location
if we were to use different smoothing parameters. Most
importantly, we see that the hotspots identified at level 1,
corresponding to our choice of the smoothing parameters, persist
at slightly larger and smaller values, confirming their validity. At
smaller levels of smoothing many spurious hotspots appear, of very
short length. There is no support from the data for these, as they
either disappear for more smoothing or they merge into larger and
more robust segments.
(TIFF)
Figure S5 Robustness plots for all hotspots, chromo-
somes chr9, chr10, chr11 and chr12. The name of each
figure identifies the chromosome and the arm and strand. In these
figures we can observe how hotspots would change in length and
location if we were to use different smoothing parameters. Most
importantly, we see that the hotspots identified at level 1,
corresponding to our choice of the smoothing parameters, persist
at slightly larger and smaller values, confirming their validity. At
smaller levels of smoothing many spurious hotspots appear, of very
short length. There is no support from the data for these, as they
either disappear for more smoothing or they merge into larger and
more robust segments.
(TIFF)
Figure S6 Robustness plots for all hotspots, chromo-
somes chr13, chr14, chr15 chr16 and chr17. The name of
each figure identifies the chromosome and the arm and strand. In
these figures we can observe how hotspots would change in length
and location if we were to use different smoothing parameters.
Most importantly, we see that the hotspots identified at level 1,
corresponding to our choice of the smoothing parameters, persist
at slightly larger and smaller values, confirming their validity. At
smaller levels of smoothing many spurious hotspots appear, of very
short length. There is no support from the data for these, as they
either disappear for more smoothing or they merge into larger and
more robust segments. Since no integration was found in p-arm of
chromosomes chr13, chr14 and chr15 in such cases only the q-arm
was plotted.
(TIFF)
Figure S7 Robustness plots for all hotspots, chromo-
somes chr18, chr19, chr20, chr21 and 22. The name of
each figure identifies the chromosome and the arm and strand. In
these figures we can observe how hotspots would change in length
and location if we were to use different smoothing parameters.
Most importantly, we see that the hotspots identified at level 1,
corresponding to our choice of the smoothing parameters, persist
at slightly larger and smaller values, confirming their validity. At
smaller levels of smoothing many spurious hotspots appear, of very
short length. There is no support from the data for these, as they
either disappear for more smoothing or they merge into larger and
more robust segments. Since no integration was found in p-arm of
chromosomes chr21 and 22 in such case only the q-arm was
plotted.
(TIFF)
Figure S8 Robustness plots for all hotspots, chromo-
somes chrX and chrY. The name of each figure identifies the
chromosome and the arm and strand. In these figures we can
observe how hotspots would change in length and location if we
were to use different smoothing parameters. Most importantly, we
see that the hotspots identified at level 1, corresponding to our
choice of the smoothing parameters, persist at slightly larger and
smaller values, confirming their validity. At smaller levels of
smoothing many spurious hotspots appear, of very short length.
There is no support from the data for these, as they either
disappear for more smoothing or they merge into larger and more
robust segments.
(TIFF)
Table S1 Comparative Hotspots. List of the hotspots. The
first column indicates the hotspot ID. Column 4 shows which virus
had most integrations. Columns 2,3,5,6,7 locates the hotspot on its
chromosome. Column 8 and 9 contain the number of integrations.
Column 10 contains the width of the hotspot. The OR (column
11) was always defined to be larger than 1. The confidence
interval, raw p-values and adjusted p-values are in columns 12–15.
The number of genes included in each hotspot is in column 16.
The Proto Oncogenes founded in each hotspot is in columns 17.
The number of Proto Oncogenes and their density with respect
the number of genes in each hotspots are reported in columns 18–
19. Number of present and absent genes are in columns 20–21.
OR of the present vs absent genes, OR confidence interval, raw p-
value and adjusted p-values are reported in columns 22–26.
(XLS)
Table S2 Gene Ontology (GO) analysis of genes targeted
by HIV and MLV comparative hotspots. 2027 and 475
genes targeted by HIV and MLV comparative hotspots were
analyzed by the DAVID Functional Annotation tool [1,2], using
the Human Genome as a background population. The table
summarizes the significantly over-represented GO categories (GO
terms) in the two datasets, after Bonferroni correction for multiple
testing. The number of genes included in each GO category is
specified (Count), together with their percentage (%) with respect
to the total number of genes in the list (List Total) and the fold
enrichment over the background. The GO class to which each
Comparative Retroviral Hotspots
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molecular function, CC: cellular compartment).
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